Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Advancements in Gastroenterology: Key Updates in Endoscopy, Liver Disease, and Cancer Research
This episode covers key updates in gastroenterology including new sedation guidelines for endoscopy, advances in pancreatic cancer organoids, dietary management of eosinophilic esophagitis, and emerging research in liver disease and cancer immunotherapy.
Bibliography
1. Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline.
Authors: Triantafyllou K, Tziatzios G, Tham TC, et al.
Journal: Endoscopy, 2026 Oct
PMID: 42480549
DOI: 10.1055/a-2898-6540
2. Human Pancreatic Cancer Organoids.
Authors: He A, Lin X, Qian X, et al.
Journal: Cell proliferation, 2026 Oct
PMID: 42026891
DOI: 10.1111/cpr.70210
3. Dietary Approaches in Eosinophilic Esophagitis.
Authors: Arraf T, Chahuán J, Bertin L, et al.
Journal: Nutrients, 2026 Sep 18
PMID: 42797036
DOI: 10.3390/nu18183053
4. Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer.
Authors: Dieci MV, Gasparini E, Nicolé L, et al.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research, 2026 Oct 1
PMID: 42467210
DOI: 10.1158/1078-0432.CCR-26-0975
5. Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
Authors: Scaldaferri F, Di Vincenzo F, Aloi M, et al.
Journal: The American journal of gastroenterology, 2026 Oct 1
PMID: 41705712
DOI: 10.14309/ajg.0000000000003969
6. Ferroptosis in liver biology and diseases.
Authors: Cao P, He P, Du K, et al.
Journal: Hepatology communications, 2026 Oct 1
PMID: 42809682
DOI: 10.1097/HC9.0000000000001058
7. Igniting antitumour immunity with cancer cell pyroptosis.
Authors: Liu X, Goldberg E, Kagan JC, et al.
Journal: Nature reviews. Cancer, 2026 Oct
PMID: 42509327
DOI: 10.1038/s41568-026-00959-3
8. Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.
Authors: Giganti F, Leni R, Wagaskar V, et al.
Journal: European radiology, 2026 Oct
PMID: 42080884
DOI: 10.1007/s00330-026-12570-z
9. Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.
Authors: Bowlus CL, Bittencourt PL, Bobat B, et al.
Journal: The American journal of gastroenterology, 2026 Oct 1
PMID: 42148535
DOI: 10.14309/ajg.0000000000004054
10. The changing epidemiology of primary liver cancer in the 21(st) century.
Authors: Khan SA, Vithayathil M, Yip TCF, et al.
Journal: Journal of hepatology, 2026 Oct
PMID: 42542384
DOI: 10.1016/j.jhep.2026.01.018
Authors: Triantafyllou K, Tziatzios G, Tham TC, et al.
Journal: Endoscopy, 2026 Oct
PMID: 42480549
DOI: 10.1055/a-2898-6540
2. Human Pancreatic Cancer Organoids.
Authors: He A, Lin X, Qian X, et al.
Journal: Cell proliferation, 2026 Oct
PMID: 42026891
DOI: 10.1111/cpr.70210
3. Dietary Approaches in Eosinophilic Esophagitis.
Authors: Arraf T, Chahuán J, Bertin L, et al.
Journal: Nutrients, 2026 Sep 18
PMID: 42797036
DOI: 10.3390/nu18183053
4. Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer.
Authors: Dieci MV, Gasparini E, Nicolé L, et al.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research, 2026 Oct 1
PMID: 42467210
DOI: 10.1158/1078-0432.CCR-26-0975
5. Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
Authors: Scaldaferri F, Di Vincenzo F, Aloi M, et al.
Journal: The American journal of gastroenterology, 2026 Oct 1
PMID: 41705712
DOI: 10.14309/ajg.0000000000003969
6. Ferroptosis in liver biology and diseases.
Authors: Cao P, He P, Du K, et al.
Journal: Hepatology communications, 2026 Oct 1
PMID: 42809682
DOI: 10.1097/HC9.0000000000001058
7. Igniting antitumour immunity with cancer cell pyroptosis.
Authors: Liu X, Goldberg E, Kagan JC, et al.
Journal: Nature reviews. Cancer, 2026 Oct
PMID: 42509327
DOI: 10.1038/s41568-026-00959-3
8. Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.
Authors: Giganti F, Leni R, Wagaskar V, et al.
Journal: European radiology, 2026 Oct
PMID: 42080884
DOI: 10.1007/s00330-026-12570-z
9. Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.
Authors: Bowlus CL, Bittencourt PL, Bobat B, et al.
Journal: The American journal of gastroenterology, 2026 Oct 1
PMID: 42148535
DOI: 10.14309/ajg.0000000000004054
10. The changing epidemiology of primary liver cancer in the 21(st) century.
Authors: Khan SA, Vithayathil M, Yip TCF, et al.
Journal: Journal of hepatology, 2026 Oct
PMID: 42542384
DOI: 10.1016/j.jhep.2026.01.018
